Abstract
The Bethesda guidelines may offer more useful criteria in patients’ selection for germline mismatch repair gene mutation analysis than guidelines merely based on family background. An early onset double primary colorectal cancer patient with poor family history with MSI-H status was investigated for MLH1 promoter methylation, expression of the MLH1 and MSH2 gene by immunohistochemistry and mutations in the MLH1 and MSH2 genes. The index patient carried two germline alterations, the p.Val716Met in MLH1 and the c.2210+lG>C in MSH2 genes, and both tumors failed to express MLH1 and MSH2 proteins. After subsequent analysis of the whole family of the index patient, the p.Val716Met variant can be defined as a rare polymorphism with the possible contribution of pathogenicity to tumor formation and c.2210+1G>C as a true pathogenic mutation causing an out-of-frame deletion of exon 13.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Cunningham JM, Christensen ER, Tester DJ, et al: Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res 58: 3455–3460, 1998.
Wang Q, Lasset C, Desseigne F, et al: Prevalence of germline mutations of hMLH1, hMLS2, hPMS1, hPMS2, and hMSH6 genes in French kindreds with nonpolyposis colorectal cancer. Hum Genet 105: 79–85, 1999.
Syngal S, Fox EA, Eng C, et al: Sensitivity and specificity of clinical criteria for hereditary non-polyposis colorectal cancer associated mutations in MSH2 and MLH1. J Med Genet 37: 641–645, 2000.
Rodriguez-Bigas MA, Boland CR, Hamilton SR, et al: A National Institute workshop on hereditary nonpolyposis colorectal cancer syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst 89: 1758–1762, 1997.
Raedle J, Trojan J, Brieger A, et al: Bethesda guidelines: Relation to microsatellite instability and MLH1 promoter methylation in patients with colorectal cancer. Ann Intern Med 135: 566–576, 2001.
Montera M, Resta N, Simone C, et al: Mutational germline analysis of hMSh2 and hMLH1 genes in early onset colorectal cancer patients. J Med Genet 37: E7, 2000.
Boland CR, Thibodeau SN, Hamilton SR, et al: A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58: 5248–5257, 1998.
Kámory E, Kolacsek O, Ottó S, et al: hMLH1 and hMSH2 somatic inactivation mechanisms in sporadic colorectal cancer patients. Pathol Oncol Res 9: 236–241, 2003.
Eads CA, Lord RV, Wickramasinghe K, et al: Epigenetic patterns in the progression of esophageal adenocarcinoma. Cancer Res 61: 3410–3418, 2001.
Beck NE, Tomlinson IPM, Homfray T, et al: Use of SSCP analysis to identify germline mutations in HNPCC families fulfilling the Amsterdam criteria. Hum Genet 99: 219–224, 1997.
Yanagisawa Y, Akiyama Y, Iida S, et al: Methylation of the hMLH1 promoter in familial gastric cancer with microsatellite instability. Int J Cancer 85: 50–53, 2000.
Wahlberg SS, Schmeits J, Thomas G, et al: Evaluation of microsatellite instability and immunohistochemistry for the prediction of germ-line MSH2 and MLH1 mutations in hereditary nonpolyposis colon cancer families. Cancer Res 62: 3485–3492, 2002.
Hendriks Y, Franken P, Dierssen TW, et al: Conventional and tissue microarray immunohistochemical expression analysis of mismatch repair in hereditary colorectal tumors. Am J Pathol 162: 469–477, 2003.
Raut CP, Pawlik TM, Rodriguez-Bigas MA: Clinicopathologic features in colorectal cancer patients with microsatellite instability. Mut Res. 568:275–282, 2004.
Hutter P, Couturier A, Membrez V, et al: Excess of hMLH1 germline mutations in Swiss families with hereditary non-polyposis colorectal cancer. Int J Cancer 78: 80–84, 1998.
Cederquist K, Emanuelsson M, Goransson I, et al: Mutation analysis of the MLH1, MSH2 and MSH6 genes in patients with double primary cancers of the colorectum and the endometrium: a population-based study in northern Sweden. Int J Cancer 109: 370–376, 2004.
http://prodes.toulouse.inra.fr
Kurzawski G, Suchy T, Kladny T, et al: Germline MSH2 and MLH1 mutational spectrum in HNPCC families from Poland and the Baltic States. J Med Genet 39: E65, 2002.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kámory, E., Tanyi, M., Kolacsek, O. et al. Two germline alterations in mismatch repair genes found in a HNPCC patient with poor family history. Pathol. Oncol. Res. 12, 228–233 (2006). https://doi.org/10.1007/BF02893417
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02893417